Limosilactobacillus fermentum, Current Evidence on the Antioxidant Properties and Opportunities to be Exploited as a Probiotic Microorganism.
Luciana Caroline Paulino do NascimentoDiego Cabral LacerdaDiorginis José Soares FerreiraEvandro Leite de SouzaJosé Luiz de Brito AlvesPublished in: Probiotics and antimicrobial proteins (2022)
The unbalance in the production and removal of oxygen-reactive species in the human organism leads to oxidative stress, a physiological condition commonly linked to the occurrence of cancer, neurodegenerative, inflammatory, and metabolic disorders. The implications of oxidative stress in the gut have been associated with gut microbiota impairments and gut dysbiosis. Some lactobacilli strains have shown an efficient antioxidant system capable of protecting against oxidative stress and related-chronic diseases. Recently, in vitro and experimental studies and some clinical trials have demonstrated the efficacy of the administration of various Limosilactobacillus fermentum strains to modulate beneficially the host antioxidant system resulting in the amelioration of a variety of systemic diseases phenotypes. This review presents and discusses the currently available studies on identifying L. fermentum strains with anti-oxidant properties, their sources, range of the administered doses, and duration of the intervention in experiments with animals and clinical trials. This review strives to serve as a relevant and well-cataloged reference of L. fermentum strains with capabilities of inducing anti-oxidant effects and health-promoting benefits to the host, envisaging their broad applicability to disease control.
Keyphrases
- oxidative stress
- clinical trial
- escherichia coli
- diabetic rats
- induced apoptosis
- dna damage
- ischemia reperfusion injury
- anti inflammatory
- endothelial cells
- healthcare
- risk assessment
- public health
- case control
- squamous cell carcinoma
- mental health
- health information
- drinking water
- signaling pathway
- open label
- heat shock
- young adults
- phase ii
- human health
- double blind
- health promotion
- lymph node metastasis
- childhood cancer